UCB, Inc. v. Mylan Techs. Inc. – Neupro® (Rotigotine)

Case Name: UCB, Inc. v. Mylan Techs. Inc., Civ. No. 22-cv-216 (D. Vt. Mar. 8, 2024) (Reiss, J.) – Drug Product and Patent(s)-in-Suit: Neupro® (rotigotine); U.S. Patents Nos. 8,246,979 (“the ’979 patent”) and 8,246,980 (“the ’980 patent”)….
By: Robins Kaplan LLP
Previous Story

Account Takeover and Business Email Compromise Fraud: Legally Puzzling Payments Problems

Next Story

That’s All Capital Gain Right? Income Taxes and Intellectual Property Monetization